Inflammation, immune activation, immunosenescence, and hormonal biomarkers in the frailty-related phenotype of men with or at risk for HIV infection

Journal of Infectious Diseases

Volumn 215, Issue 2, 2017, Pages 228-237

  Erlandson, Kristine M ^a   Ng, Derek K ^b   Jacobson, Lisa P ^b   Margolick, Joseph B ^b   Dobs, Adrian S ^b   Palella, Frank J ^d   Lake, Jordan E ^e   Bui, Hanhvy ^b   Kingsley, Lawrence ^f   Brown, Todd T ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

aging; frailty; HIV; inflammation; hormones

Indexed keywords

BIOLOGICAL MARKER; HORMONE;

ADULT; BLOOD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSENESCENCE; INFLAMMATION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADULT; BIOMARKERS; HIV INFECTIONS; HORMONES; HUMANS; IMMUNOSENESCENCE; INFLAMMATION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 85021857477     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw523     Document Type: Article

References (49)

1. Fried LP. Conference on the physiologic basis of frailty. April 28, 1992, Baltimore, Maryland, U.S.A. Introduction. Aging (Milano) 1992; 4:251-2.
2. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146-56.
3. Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci 2007; 62:738-43.
4. Robinson TN, Wu DS, Stiegmann GV, Moss M. Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults. Am J Surg 2011; 202:511-4.
5. Margolick JB, Chopra RK. Relationship between the immune system and frailty: pathogenesis of immune deficiency in HIV infection and aging. Aging (Milano) 1992; 4:255-7.
6. Desquilbet L, Jacobson LP, Fried LP, et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007; 62:1279-86.
7. Desquilbet L, Margolick JB, Fried LP, et al. Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 2009; 50:299-306.
8. Desquilbet L, Jacobson LP, Fried LP, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci 2011; 66:1030-8.
9. Akgun KM, Tate JP, Crothers K, et al. An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals. J Acquir Immune Defic Syndr 2014; 67:397-404.
10. Fried LP, Xue QL, Cappola AR, et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci 2009; 64:1049-57.
11. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
12. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1-19.
13. DHHS/Henry J. Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. January 2016 revision. https://aidsinfo. nih.gov/guidelines/html/1/adult-And-Adolescent-Treatment-guidelines/0/. Accessed 5 August 2016.
14. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Measur 1977; 1:385-401.
15. Ng DK, Jacobson LP, Brown TT, et al. HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection. AIDS 2014; 28:377-86.
16. Schenker EL, Hultin LE, Bauer KD, Ferbas J, Margolick JB, Giorgi JV. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry 1993; 14:307-17.
17. Hultin LE, Menendez FA, Hultin PM, et al. Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods. Cytometry B Clin Cytom 2007; 72:249-55.
18. Crawford KW, Li X, Xu X, et al. Lipodystrophy and inflammation predict later grip strength in HIV-infected men: The MACS Body Composition substudy. AIDS Res Hum Retroviruses 2013; 29:1138-45.
19. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84:3666-72.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-9.
21. Wada NI, Jacobson LP, Margolick JB, et al. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS 2015; 29:463-71.
22. Erlandson KM, Allshouse AA, Jankowski CM, et al. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis 2013; 208:249-59.
23. Margolick JB, Martinez-Maza O, Jacobson L, et al. Frailty and circulating markers of inflammation in HIV+ and HIV-men in the Multicenter AIDS Cohort Study. Presented at: Conference on Retroviruses and Opportunistic Infections; 3-6 March 2013: Atlanta, GA. Abstract 800.
24. Piggott DA, Varadhan R, Mehta SH, et al. Frailty, inflammation, and mortality among persons aging with HIV infection and injection drug use. J Gerontol A Biol Sci Med Sci 2015; 70:1542-7.
25. Escota GV, Patel P, Brooks JT, et al. Short communication: The Veterans Aging Cohort Study index is an effective tool to assess baseline frailty status in a contemporary cohort of HIV-infected persons. AIDS Res Hum Retroviruses 2015; 31:313-7.
26. Kooij KW, Wit FW, Schouten J, et al. HIV infection is independently associated with frailty in middle-Aged HIV type 1-infected individuals compared with similar but uninfected controls. AIDS 2016; 30:241-50.
27. Serrano-Villar S, Sainz T, Lee SA, et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 2014; 10:e1004078.
28. Baylis D, Bartlett DB, Syddall HE, et al. Immune-endocrine biomarkers as predictors of frailty and mortality: A 10-year longitudinal study in community-dwelling older people. Age 2013; 35:963-71.
29. Afilalo J. Androgen deficiency as a biological determinant of frailty: hope or hype? J Am Geriatr Soc 2014; 62:1174-8.
30. Voznesensky M, Walsh S, Dauser D, Brindisi J, Kenny AM. The association between dehydroepiandosterone and frailty in older men and women. Age Ageing 2009; 38:401-6.
31. Cappola AR, Xue QL, Fried LP. Multiple hormonal deficiencies in anabolic hormones are found in frail older women: The Womens Health and Aging studies. J Gerontol A Biol Sci Med Sci 2009; 64:243-8.
32. Sanders JL, Ding V, Arnold AM, et al. Do changes in circulating biomarkers track with each other and with functional changes in older adults? J Gerontol A Biol Sci Med Sci 2014; 69:174-81.
33. Tajar A, OConnell MD, Mitnitski AB, et al. Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-Testicular axis in older men: results from the European male aging study. J Am Geriatr Soc 2011; 59:814-21.
34. Althoff KN, Jacobson LP, Cranston RD, et al. Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci 2014; 69:189-98.
35. Erlandson KM, Allshouse AA, Jankowski CM, et al. Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy. HIV Clin Trials 2012; 13:324-34.
36. Rochira V, Diazzi C, Santi D, et al. Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: A retrospective study. Andrology 2015; 3:298-308.
37. Erlandson KM, Allshouse AA, Jankowski CM, MaWhinney S, Kohrt WM, Campbell TB. Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection. J Acquir Immune Defic Syndr 2013; 63:209-15.
38. Villette JM, Bourin P, Doinel C, et al. Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab 1990; 70:572-7.
39. Jacobson MA, Fusaro RE, Galmarini M, LangW. Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. J Infect Dis 1991; 164:864-8.
40. Baker WL, Karan S, Kenny AM. Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: A systematic review. J Am Geriatr Soc 2011; 59:997-1002.
41. Kenny AM, Boxer RS, Kleppinger A, Brindisi J, Feinn R, Burleson JA. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J Am Geriatr Soc 2010; 58:1707-14.
42. Nair KS, Rizza RA, OBrien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006; 355:1647-59.
43. Seftel AD, Kathrins M, Niederberger C. Critical update of the 2010 Endocrine Society clinical practice guidelines for male hypogonadism: A systematic analysis. Mayo Clin Proc 2015; 90:1104-15.
44. Janssen SP, Gayan-Ramirez G, Van den Bergh A, et al. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 2005; 111:996-1005.
45. Baltgalvis KA, Berger FG, Pena MM, Davis JM, Muga SJ, Carson JA. Interleukin-6 and cachexia in ApcMin/+ mice. Am J Physiol Regul Integr Comp Physiol 2008; 294:R393-401.
46. White JP, Puppa MJ, Sato S, et al. IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse. Skeletal Muscle 2012; 2:14.
47. van Hall G, Steensberg A, Fischer C, et al. Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals. J Clin Endocrinol Metab 2008; 93:2851-8.
48. Ng TP, Feng L, Nyunt MS, et al. Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: A randomized controlled trial. Am J Med 2015; 128:1225-36 e1.
49. Erlandson KM, Campbell TB. Inflammation in chronic HIV infection: what can we do? J Infect Dis 2015; 212:339-42.